Review
Published on 22 Nov 2024
Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)
in Drugs Outcomes Research and Policies
- 180 views
Review
Published on 22 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 20 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 20 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 20 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 20 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 19 Nov 2024
in Drugs Outcomes Research and Policies
Systematic Review
Published on 19 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 19 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 18 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 15 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Accepted on 14 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 14 Nov 2024
in Drugs Outcomes Research and Policies
Policy Brief
Published on 14 Nov 2024
in Drugs Outcomes Research and Policies
Brief Research Report
Published on 13 Nov 2024
in Drugs Outcomes Research and Policies
Systematic Review
Published on 13 Nov 2024
in Drugs Outcomes Research and Policies
Original Research
Published on 12 Nov 2024
in Drugs Outcomes Research and Policies